未登录

K

Klemens Fheodoroff

kabeg gailtal-klinik

H指数:17

被引数:946

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Active Function Improvement with Repeated Injections of Botulinum Toxin A in Upper Limb Spasticity: A Longitudinal Analysis from the ULIS-III Study

重复注射肉毒毒素A改善上肢痉挛的主动功能：ULIS-III研究的纵向分析

IF4

2026-10-030

OA

Early recognition of post-stroke spasticity: the I-REFER study

卒中后痉挛的早期识别：I-REFER研究

Frontiers in Neurology

IF2.8

2026-05-190

OAAI

Longitudinal, Multi-Cycle Evaluation of Passive Function Improvement in People with Arm Spasticity Treated with Botulinum Toxin A

IF4

2026-01-190

OAAI

Pain Reduction with Repeated Injections of Botulinum Toxin A in Upper Limb Spasticity: A Longitudinal Analysis from the ULIS-III Study

上肢痉挛时反复注射肉毒杆菌毒素A可减轻疼痛: 来自ULIS-III研究的纵向分析

IF4

2025-03-010

OAAI

Improvement in Quality-of-Life-Related Outcomes Following Treatment with IncobotulinumtoxinA in Adults with Limb Spasticity: A Pooled Analysis

肢体痉挛成人接受IncobotulinumtoxinA治疗后生活质量相关结局的改善: 一项汇总分析

IF4

2023-12-291

OAAI

Improvement in spasticity-associated limb position abnormality in adults following treatment with incobotulinumtoxina: A pooled analysis

JOURNAL OF THE NEUROLOGICAL SCIENCES

IF3.2

2023-12-010

PRE

Improvement in spasticity-associated dressing- and hygiene-related disability in adults following treatment with incobotulinumtoxina: A pooled analysis

JOURNAL OF THE NEUROLOGICAL SCIENCES

IF3.2

2023-12-010

PRE

Healthcare needs, expectations, utilization, and experienced treatment effects in patients with hereditary spastic paraplegia: a web-based survey in the Netherlands

ORPHANET JOURNAL OF RARE DISEASES

IF3.5

2021-06-245

OAAI

Diagnosis and treatment of neurogenic dysphagia-S1 guideline of the German Society of Neurology

NEUROLOGICAL RESEARCH AND PRACTICE

IF3.2

2021-05-0454

OAAI

Dziewas, Rainer; Allescher, Hans-Dieter; Aroyo, Ilia; Bartolome, Gudrun; Beilenhoff, Ulrike; Bohlender, Joerg; Breitbach-Snowdon, Helga; Fheodoroff, Klemens; Glahn, Joerg; Heppner, Hans-Juergen; Hoermann, Karl; Ledl, Christian; Luecking, Christoph; Pokieser, Peter; Schefold, Joerg C.; Schroeter-Morasch, Heidrun; Schweikert, Kathi; Sparing, Roland; Trapl-Grundschober, Michaela; Wallesch, Claus; Warnecke, Tobias; Werner, Cornelius J.; Wessling, Johannes; Wirth, Rainer; Pflug, Christina

Consensus guidelines for botulinum toxin therapy: general algorithms and dosing tables for dystonia and spasticity

JOURNAL OF NEURAL TRANSMISSION

IF4

2021-02-2646

OAAI

Quality of life in subjects with upper- and lower-limb spasticity treated with incobotulinumtoxinA

接受过incobotulinumtoxinA治疗的上肢和下肢痉挛患者的生活质量

HEALTH AND QUALITY OF LIFE OUTCOMES

IF3.4

2020-03-049

OAAI

Experienced complaints, activity limitations and loss of motor capacities in patients with pure hereditary spastic paraplegia: a web-based survey in the Netherlands

ORPHANET JOURNAL OF RARE DISEASES

IF3.5

2020-03-0416

OAAI

Management of Spastic Paresis and Cervical Dystonia: Access to Therapeutic Innovations Through an International Program of Practical Courses

CLINICAL THERAPEUTICS

IF3.6

2019-11-015

OAAI

Impact of integrated upper limb spasticity management including botulinum toxin A on patient-centred goal attainment: rationale and protocol for an international prospective, longitudinal cohort study (ULIS-III)

IF2.3

2016-06-1726

OAAI

Factors Influencing Goal Attainment in Patients with Post-Stroke Upper Limb Spasticity Following Treatment with Botulinum Toxin A in Real-Life Clinical Practice: Sub-Analyses from the Upper Limb International Spasticity (ULIS)-II Study

IF4

2015-04-0822

OAAI

PATIENT-CENTERED OUTCOMES IN UPPER LIMB SPASTICITY: RESULTS FROM A LARGE INTERNATIONAL COHORT STUDY (ULIS-2)

VALUE IN HEALTH

IF6

2013-11-010

OAAI